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Background: Reference values for the incremental shuttle walking test (ISWT) which are appli-
cable to the whole population need to be solidly established. This study aimed to determine
which anthropometric and demographic variables influence the walking distance achieved in
the ISWT in healthy subjects with a broad age range and to establish a reference equation
for predicting ISWT for that population.
Methods: In a cross-sectional study, 242 healthy subjects (102 male) performed two ISWT and
had their weight, height and body mass index (BMI) measured.
Results: In general, healthy subjects walked 810 [IQR 25e75%: 572e1030] m in the ISWT,
presenting large variability (range 210e1820 m). The walked distance correlated with age (rZ
0.76), height (r Z 0.49) and BMI (r Z 0.23) (p < 0.001 for all), but not with weight
(rZ 0.06, pZ 0.315). A model of stepwise multiple regression showed that gender, age and
BMI were independent contributors to the ISWT in healthy subjects, explaining 71% (p < 0.0001)
of the variability. The derived reference equation was: ISWTpred Z 1449.701  (11.735 
age) þ (241.897  gender)  (5.686  BMI), where male genderZ 1 and female genderZ 0.
Conclusion: In conclusion, the variability of the ISWT is explained largely by gender, age and BMI.
The reference values for the ISWTcanbe adequately predicted using the equationproposed in this
study.
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Brazil, and all participants gave written informed consent.Exercise tests are commonly usedboth in clinical practice and
in scientific investigations since exercise intolerance is
a typical feature in a number of chronic diseases. The
objective assessment of exercise capacity through a cardio-
pulmonary exercise test provides information about the
causes of reduced exercise tolerance, which can be eventu-
ally improved by specific interventions.1 Moreover, outcome
parameters of exercise tests are used as guide for workload
prescription during exercise interventions.2 As laboratory
assessment is not widely available and may be expensive,
field tests such as the incremental shuttle walking test (ISWT)
have become increasingly popular.
The ISWT is a simple and inexpensive test which evalu-
ates maximal exercise capacity based on the distance
walked around a 10 m course according to different speeds
dictated by an audio signal.3 This exercise test has been
used as a predictor of mortality4 and morbidity5,6 in
patients with chronic respiratory and other diseases, as
a predictor of exacerbation in patients with pulmonary
disease,7 as well for assessing benefits of interventions8e10
and detecting oxygen desaturation during exertion.11
Although the ISWT has become very useful in clinical and
research settings, there were no reference equations to
predict the distance walked in the test by healthy subjects.
Recently, an equation was developed12; however, there are
some limitations which can compromise the external val-
idity of that study. Firstly, the sample was composed of
subjects aged 40e84 years; therefore the resulting equa-
tion is not applicable for young people. Moreover, the
coefficient of determination of its regression analysis was
relatively modest, explaining only 50% of the total variance
in the ISWT. Considering the importance of the ISWT in
assessing adequately patients of all ages with cardiopul-
monary disease and other health conditions, an equation
with higher coefficient of determination and applicable for
the whole adult population needs to be solidly established.
Hence, the aims of this study were to determine which
anthropometric and demographic variables (weight, height,
age and gender) influence the walking distance in the ISWT
of healthy subjects with a broad age range and to establish
an equation for predicting reference values of the ISWT for
this population.Methods and materialsSubjects
In a cross-sectional study, 246 healthy subjects were included
in a convenience sample. They were recruited among
students and employees of two universities in Londrina
(Brazil), as well as their relatives. Part of the sample of
subjects older than 60 years old was also composed by indi-
viduals participating in a project which investigates the
health conditions of the elderly in Londrina, Brazil (EELO
Project). All subjects had their exercise capacity, pulmonary
function, anthropometric and demographic data evaluated.
Data were collected from November 2008 to December 2010.
The study was approved (PP000709) by the Research EthicsCommittee of the Universidade Norte do Parana´ (UNOPAR),
Inclusion criteria were: subjects of both genders aged
18e83 years and absence of any severe and/or unstable
disease which could limit the exercise tolerance. Partici-
pants were excluded if they were unable to understand or
perform any procedure during the protocol or if they would
like to leave the study for any reason.
After obtaining the informed consent, a questionnaire
was applied in order to investigate health status, medica-
tion, smoking habits and whether subjects were engaged in
any regular physical activity. Height (cm) and body weight
(Kg) were measured and the body mass index (BMI) was
calculated. Spirometry (Pony Cosmed, Italy) was performed
to ensure normal lung function. The test was conducted
according to international standardization13 and the lung
function parameters obtained were forced vital capacity
(FVC), forced expiratory volume in the first second (FEV1)
and the direct measurement of maximal voluntary venti-
lation (MVV). Reference values adopted were those repor-
ted by Pereira and colleagues specifically for the Brazilian
population.14
Incremental shuttle walking test
Two incremental shuttle walking tests were performed
with, at least, 30 min of resting in between them. The tests
were performed in a 10 m course identified by two cones
placed 0.5 m from each end point.3 The best test, that is,
the longest walked distance was considered for analysis.
Participants should walk (or run) around the course
according to the speed dictated by an audio signal. The
initial walking speed was 0.5 m/s and it increased by
0.17 m/s each minute; the speed increment was always
indicated by a triple bleep. An adaptation of the modified
protocol was used, that is, the audio signals continued until
subjects reach their maximal effort, exceeding 12 levels of
speed proposed by the modified protocol and even running,
if necessary. The authors opted for adapting the protocol in
order to avoid a ceiling effect since participants were
healthy subjects and could possibly exceed the 12th level in
order to ensure their maximal effort. The tests were
executed by a physiotherapist or physiotherapy student, all
familiarized with the ISWT, and the two tests were con-
ducted by the same evaluator. The initial explanation was
standardized and no encouraging phrases were given to the
participants during the test. The ISWT was interrupted in
case of participants presented one of the following condi-
tions: if the subject could not maintain the required speed
due to dyspnea or fatigue; or if the subject failed to
complete a shuttle in the time allowed for the second time.
Heart rate (HR), arterial blood pressure, perceived dyspnea
and leg fatigue (modified Borg scale) were assessed before
and after the tests. Maximal predicted HR was calculated as
220 minus age (in years).15
Statistical analysis
The statistical analysis was performed using the statistical
packages SPSS 17.0 (SPSS Inc., USA) and GraphPad Prism
5 (GraphPd Software Inc., USA). The normality of data
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were described as median [interquartile range 25%e75%].
Wilcoxon test was used to compare outcome parameters of
the ISWT. ManneWhitney test was used to compare subjects’
characteristics betweenmale and female genders. Spearman
correlation coefficients were calculated and a model of
multiple linear regression was applied (ISWT distance as
dependent variable; demographic and anthropometric data
as independent variables) since its standardized residual
presented normal distribution (p Z 0.785). The Bland &
Altman plot was used to evaluate agreement between the
actual ISWT distance and the predicted value. In order to
verify the reliability of the regression equation, it was
applied a posteriori in a different group of healthy subjects,
composed by 23 individuals selected according to the same
inclusion criteria of the present sample. The level of statis-
tical significance was considered as p < 0.05.
Results
The study sample included 103 male and 143 female
apparently healthy subjects. Four subjects (1 man and 3
women) were excluded because they interrupted the test
abruptly due to severe joint pain. Therefore, the results of
242 subjects are presented. The subjects’ age ranged from
18 to 83 years. They presented normal lung function and, in
general, a normal body composition. As expected, men
were taller and weighed more than women, as well as
presented higher distance walked in the ISWT in absolute
values (Table 1).
Health status, medication, smoking habits and
physical activity level
The comorbidities more prevalent among the study
subjects were systemic hypertension (34%), followed by
peripheral vascular disease (24%) and arthritis (22%). Other
reported comorbidities were: stable cardiac disease (13%),
diabetes mellitus (13%), thyroid disorders (8%), osteoporosis
(6%) and asthma (6%). One hundred and forty three
participants (41% among those were elderly) needed to take
some medication continuously. The medications were
prescribed by physicians and were related to the specificTable 1 Characteristics of the study subjects.
Total group (n Z 242) Male (
Age (yrs) 50 [31e66] 49 [30
Height (m) 1.64 [1.58e1.71] 1.71 [
Weight (Kg) 69 [60e79] 75 [68
BMI (kg m2) 26 [23e29] 27 [23
FEV1/FVC 89 [83e95] 87 [82
FEV1 %pred 97 [89e106] 96 [89
FVC %pred 94 [85e104] 92 [86
MVV %pred 98 [81e110] 103 [8
ISWT (m) 810 [572e1030] 1010 [
Data are expressed as median [interquartile range 25e75%]. P-value c
body mass index; FEV1: forced expiratory volume in the first second;
ISWT: incremental shuttle walking test.health condition presented by the individual. Among the
medications in use, 45% were drugs known to affect blood
pressure and/or heart rate. Approximately 30% of the
subjects were current smokers. Regarding the physical
activity level, 61% of participants were not engaged in
regular physical activity.
Variability of the ISWT
Considering the best of the two ISWT, subjects walked 810
[572e1030] m, presenting large variability (range of
210e1820 m). Twenty-eight percent of subjects exceeded
the 12th level of the protocol, presenting a walked distance
higher than 1020 m. Subjects walked a median of 770
[530e1010] m in the first ISWT and 790 [550e1030] m in the
second ISWT (p < 0.0001) (Table 2). The distance walked
during the second ISWT increased by 20 [10e70] m
(increment of 3%); 63% of subjects had their best ISWT in
the second test and 28% in the first test, whereas 9% of the
individuals had the exact same distance in the two tests.
When comparing genders, male walked farther than female
(1010 [755e1200] m vs. 720 [480e910] m, p < 0.0001,
respectively). In the best test, subjects reached 99
[89e105]% of their maximal predicted HR.
ISWT determinants and reference equation
There were significant correlations between the distance
walked in the ISWT with age (r Z 0.76), BMI (r Z 0.23)
and height (r Z 0.49) (p < 0.001 for all), but not with
weight (rZ 0.06, pZ 0.315). A model of stepwise multiple
regression showed that gender, age and BMI explained 71%
(p < 0.0001) of the variability in the ISWT. Unstandardized
coefficients, part correlation and significance are shown in
Table 3. The reference equation for the distance walked in
the ISWT was:
ISWTpredZ1449:701 ð11:735 ageÞ þ ð241:897 genderÞ
ð5:686 BMIÞ
(where male gender Z 1 and female gender Z 0).
The Bland & Altman plot shows the agreement between
the actual ISWT and the predicted value obtained from the
reference equation (Fig. 1). A weak but significantn Z 102) Female (n Z 140) p-value
e69] 51 [33e66] 0.989
1.66e1.75] 1.59 [1.55e1.64] <0.0001
e85] 64 [57e72] <0.0001
e29] 25 [21e29] 0.146
e93] 89 [85e99] 0.044
e106] 97 [89e106] 0.793
e103] 94 [85e104] 0.772
9e113] 93 [77e105] <0.0001
755e1200] 720 [480e910] <0.0001
oncerns the difference between male and female subjects. BMI:
FVC: forced vital capacity; MVV: maximal voluntary ventilation;
Table 2 Outcome parameters of the two incremental shuttle walking tests.
ISWT 1 ISWT 2 p-value
ISWT (m) 770 [530e1010] 790 [550e1030] <0.0001
% HR max (%) 96 [84e102] 99 [90e105] <0.0001
SBP before (mmHg) 120 [110e130] 120 [110e130] 0.483
SBP end (mmHg) 160 [150e180] 165 [150e190] 0.959
DSBP (mmHg) 40 [20e60] 40 [30e60] 0.613
DBP before (mmHg) 80 [70e80] 80 [70e80] 0.908
DBP end (mmHg) 80 [80e90] 80 [80e90] 0.862
DDBP (mmHg) 10 [0e10] 0 [0e10] 0.863
Borg D before (pts) 0 [0e0] 0 [0e0] 0.128
Borg D end (pts) 4 [2e6] 4 [3e6] 0.026
DBorg D (pts) 4 [2e5] 4 [2e6] 0.190
Borg F before (pts) 0 [0e0.5] 0 [0e0.5] 0.541
Borg F end (pts) 2 [0e4] 3 [0e4] 0.199
DBorg F (pts) 1 [0e4] 2 [0e4] 0.400
Data are expressed as median [interquartile range 25e75%]. ISWT: incremental shuttle walking test; HR: heart rate; SBP: systolic blood
pressure; DBP: diastolic blood pressure; Borg D: Borg dyspnea scale; Borg F: Borg fatigue scale.
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ISWT (actual e predicted) and the mean of the ISWT (actual
and predicted) (r Z 0.28, p < 0.0001).
Since the mean  standard deviation distance walked in
the ISWT was 833  273 m, the lower limit of normal
calculated according to the confidence interval was 798 m.
Reliability of the reference equation
The characteristics of the other group composed by 23
healthy subjects (10 male) included in the a posteriori
analysis were: age 49  20 years, BMI 24  3.8 kg m2, FEV1
93  15%pred and FVC 91  17%pred. When the reference
equation was applied in this group, there was no difference
between the actual and predicted ISWT (839  269 m vs.
838  271 m, respectively; pZ 0.970). Furthermore, there
was a strong correlation between the actual and predicted
ISWT (r Z 0.85, p < 0.0001).
Discussion
The present study demonstrated that healthy subjects aged
from 18 to 83 years present large variability in the ISWT
(210e1820 m), and that 71% of this variance is explained by
age, gender and body mass index. Moreover, a reference
equation was established using anthropometric andTable 3 Multiple linear regression analysis with ISWT as the de
Unstandardized
coefficients (B)
95% Confid
interval fo
Constant 1449.701 1316.884e
Age (yrs) 11.735 12.867 t
Gendera 241.897 198.491e2
BMI (kg m2) 5.686 10.832 t
Residual standard deviation Z 167.8 m.
The derived equation from the regression analysis was:
ISWTpred Z 1449.701  (11.735  age) þ (241.897  gender)  (5.68
a Male gender Z 1 and female gender Z 0.demographic variables which can be easily applied in clin-
ical and research settings.
Recently, a Brazilian research group has published
a reference equation for the ISWT.12 However, there were
some limitations in their study which could limit the use of
the equation. Firstly, the analysis did not include subjects
younger than 40 years old, which is a limitation since some
cardiopulmonary diseases affect subjects in this age range.
Secondly, the regression coefficient was modest (50%),
increasing the chance of bias in predicting the walking
distance in the ISWT. In fact, this was confirmed when that
equation12 was applied in our sample studied a posteriori.
The predicted value was greatly underestimated when
comparedwith the actual ISWT (579 173mvs. 839 269m,
p < 0.0001, respectively), which corresponds to a 45%
difference. This discrepancy did not happen when the
equation from the present study was used. Finally, those
authors considered for the statistical analysis only the
second test instead of the best test. This approach could
definitely have influenced the results since itwas observed in
our study that almost one in each three subjects was able to
walk farther during the first ISWT.
The present results demonstrated that gender, age and
BMI influence the ISWT in apparently healthy subjects.
These findings are in agreement with previously published
data about walking speed. In a study with 42 male subjects,
Pearce et al.16 affirmed that age alone was associated withpendent variable.
ence
r B
p-value Part correlation
1582.519
o 10.603 <0.0001 0.70
85.302 <0.0001 0.38
o 0.539 0.031 0.07
6  BMI).
Figure 1 Bland & Ajtman plot of the difference between the
actual and predicted value of the ISWT plotted against the mean
of the actual and the predicted value of the ISWT for the entire
subject group. The central dotted line corresponds to the
average difference between the actual and predicted value of
the ISWT, whereas the lower and upper dotted lines corresponds
to lower and upper limits of agreement, respectively.
Reference values for the ISWT 247walking speed. Himann et al.17 also found that age was the
only significant independent predictor for walking speed
when 438 subjects aged 19e102 years walked over an 80-m
indoor course. Bohannon18 studied 1923 subjects who had
their gait speed evaluated when walking in a corridor, and
showed that younger, male and taller individuals walk
faster. Recently,19 the same author observed that body
composition also influences the walking ability in elderly
people, demonstrating that higher BMI was significantly
associated with limited walking (r Z 0.42). A negative
association between adiposity and walking speed in older
women was also observed by Ortega-Alonso et al.20
Previous studies have shown that patients reach higher
peak HR during the ISWT than during the 6-min walking
test, characterizing the ISWT as a maximal exercise
test.3,21 Furthermore, in our study, the peak HR was even
higher than those reported previously,3,21 since partici-
pants achieved 99% of their maximal predicted HR. It can
be attributed to the fact that our sample was composed of
healthy subjects, who do not present any ventilatory or
cardiovascular limitation, differently from the subjects
included in those studies. In contrast, Ju¨rgensen et al.12
reported that healthy subjects reached only 78% of their
maximal predicted HR when performing the ISWT, which
represents 21% less in comparison to the healthy subjects
from the present study. This possibly represents a meth-
odological issue in the study of Ju¨rgensen et al., since it
might be that those subjects did not perform their maximal
effort during the ISWT.
The majority of subjects increased their walking
distance during the second test with an average improve-
ment of 20 m. This is in accordance with results previously
reported, in which the magnitude of the improvement in
the second test ranges from 20 to 40 m.3,22,23Strengths and limitations
The clinical importance of our findings is evident since the
use of absolute values in assessing patients usually induces
bias in the results. The use of a reference equation for theISWT correcting values for gender, age and BMI allows
interpreting the results adequately taking into account
each subject’s characteristics, enabling more reliable
intergroup comparisons.
Although a reference equation for the ISWT has been
recently published, some points in the present study update
thosefindings. Firstly, our sample includeda highernumber of
subjects (242 vs. 131 subjects) and ages from 18 to 83 years,
being more representative of the vast majority of cardiopul-
monary patient’s population. Secondly, in our analysis, the
anthropometric and demographic variables could explain
a larger part of the variance in the ISWT (71%). Thirdly, our
sample reached a higher HR in terms of % predicted of the
maximal HR, suggesting more effort during the test.
Despite all efforts, some limitations occurred. A few
variables which could also explain the variance in the ISWT
were not assessed, such as peripheral muscle force and
balance. On the other hand, this study aimed at estab-
lishing a reference equation using independent variables
which are easily available in clinical settings. Another
limitation was the use of a convenience sample, although
caution was taken concerning the number of participants in
each age range, as well as the proportion of male and
female subjects. Finally, it can be speculated that the
subjects from the present study could have performed even
better if a third ISWT was performed instead of two.
However, it has been shown that a third ISWT had no
benefit in terms of walking distance in patients following
artery bypass.24 Therefore, we hypothesized that this could
also be the case for people without cardiac disease.
Nevertheless, the necessity of performing a third ISWT still
remains to be completely elucidated in healthy individuals.
Conclusions
In summary, it can be concluded that variability in the
performance of the incremental shuttle walking test in
healthy people can be explained (71%) by using age, gender
and body mass index. A reference equation could be
established based on these anthropometric and demo-
graphic variables. Standardization of the ISWT is necessary
to ensure maximal effort during the test in order to avoid
incorrect interpretation of results when considering refer-
ence values.
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